Möchten Sie immer auf dem neuesten Stand bleiben?

REGULATED INFORMATION GHENT, Belgium, Jan. 20, 2014 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal...

GHENT, Belgium, Jan. 13, 2014 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX] today announced that it will present at the 32nd Annual J.P. Morgan Healthcare Conference on Thursday 16 January...

GHENT, Belgium, Dec. 5, 2013 (GLOBE NEWSWIRE) -- REGULATED INFORMATION Ablynx [Euronext Brussels: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the...

REGULATED INFORMATION GHENT, Belgium, Nov. 26, 2013 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree...

REGULATED INFORMATION GHENT, Belgium, Nov. 25, 2013 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX], today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding...

REGULATED INFORMATION GHENT, Belgium, Nov. 18, 2013 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels:ABLX] has been informed that Sofinnova Partners SAS has successfully completed a private placement...

REGULATED INFORMATION A period of transformation with major new collaborations, advances in the clinical pipeline, important developments in the shareholder structure and establishment of a fully...

GHENT, Belgium, Oct. 31, 2013 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels:ABLX] today announced that it has received notice of a €1.68 million in grant funding from the Flemish Agency for...

GHENT, Belgium, Oct. 30, 2013 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major...

GHENT, Belgium, Oct. 29, 2013 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels:ABLX] today announced that its partner Boehringer Ingelheim has dosed the first healthy volunteers in a Phase I clinical...